Hemostasis and hemostatic agents in minimally invasive surgery

Torre, Roger A. de la; Bachman, Sharon L.; Wheeler, Andrew A.; Bartow, Kevin N.; Scott, James S.

doi:10.1016/j.surg.2007.06.023

Cited by 39 publications

(24 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Considering the morbidity, mortality, and extended hospitalization due to uncontrolled severe traumatic or surgical bleeding, the timely control of bleeding has obvious benefits for patients and for surgeons, and is an active area of research [11][12][13][14]. Surgeons encounter bleeding from a variety of tissue types, intensity, and etiologies.…”

Section: Discussionmentioning

confidence: 99%

“…These products have proven most efficacious in controlling slowly bleeding foci, diffuse oozing, bleeding from needle puncture sites, and diffuse parenchymal organ hemorrhage. They are not as effective in the control of some forms of active or severe bleeding where the topically applied agents can be simply carried away from the bleeding site by actively flowing blood or require a dry field for application [11,12]. Timely control of bleeding has obvious benefits for patients and for surgeons.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Hemostatic Effectiveness of Fibrin Pad After Partial Nephrectomy in Swine

Hutchinson

Broughton

Barbolt

et al. 2011

Journal of Surgical Research

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Hemostatic Effectiveness of Fibrin Pad After Partial Nephrectomy in Swine

Hutchinson

Broughton

Barbolt

et al. 2011

Journal of Surgical Research

View full text Add to dashboard Cite

“…Some agents promote a diminished pH on nearby environments, disrupting local innate defense immune mechanisms such as protease activity [1,10]. On the other hand, oxidized regenerated cellulose hemostatics are considered bactericidal, due to their acidifi cation of the media [2].…”

Section: Incorrect Amounts and Disposal Of Hemostatic Agentsmentioning

confidence: 99%

“…Alternative to the standard suture materials and energy devices, a great variety of topical hemostatic agents and tissue adhesives are currently available as to improve outcomes such as reduced blood loss, need for blood transfusion, shorter surgery times and risk for reintervention [1,2].…”

Section: Introductionmentioning

confidence: 99%

Case Report: Pelvic abscess formation secondary to the use of commercial hemostatic topical agent in an immunocompromised patient?

Monzón-Vargas¹,

Meraz²,

Ayala-Yáñez³

2017

J Gynecol Res Obstet

View full text Add to dashboard Cite

Clinical Group AbstractVarious hemostatic agents are currently available for routine laparoscopic procedures, avoiding thermal lesions due to energy devices and the complexity of intracorporeal sutures, however, evidence of complications in immunocompromised patients is still lacking. We present the case of a severely immunocompromised gynecological patient who underwent a routine laparoscopic cystectomy, where a local hemostatic agent was employed; further complications arose, a second diagnostic laparoscopy revealed a pelvic abscess with severe adhesion formation. All under a complicated clinical setting due to an impaired immune response, whether this abscess was caused due to the hemostatic agent or other patient's conditions remains to be determined, still, various clinical factors and patient's response need to be taken into account as the cause of the abscess formation.

show abstract

“…In this regard, uncontrollable bleeding is one of the most considerable risks brought on from indirect access to the surgery operation site [5]. Even a minor jet bleeding during MIS may cover the lens and distort the vision while it may cause significant laparoscope light absorption and darken the surgical area [6]. In some cases, conversion of laparoscopy to laparotomy could be essential to achieve adequate haemostasis [5,7].…”

Section: Introductionmentioning

confidence: 99%

A novel haemostatic powder delivery device applicable in minimally invasive surgery

Darbemamieh

Hashemi

Kordestani

et al. 2013

Journal of Medical Engineering & Technology

View full text Add to dashboard Cite

Haemostatic powder is an effective solution commonly used in various open surgeries. However, there is no specific intra-abdominal delivery device for application of haemostatic powder at the bleeding site during minimally invasive surgery (MIS). In this study, design, construction and test of a novel powder delivery device were carried out. The device uses pressurized gas to deliver the haemostatic powder to the bleeding point. The effect of the gas pressure and the spraying distance on the geometry of the powder dispersion surface area was investigated and found to be significant. The findings indicate that the driving gas pressure range of 60-80 mmHg and the spraying distance range of 2-5 cm achieve the most concentrated powder dispersion surface area. Additionally, in vivo experiments confirmed the effectiveness of the device in live tissue.

show abstract

Hemostasis and hemostatic agents in minimally invasive surgery

Cited by 39 publications

References 36 publications

Hemostatic Effectiveness of Fibrin Pad After Partial Nephrectomy in Swine

Hemostatic Effectiveness of Fibrin Pad After Partial Nephrectomy in Swine

Case Report: Pelvic abscess formation secondary to the use of commercial hemostatic topical agent in an immunocompromised patient?

A novel haemostatic powder delivery device applicable in minimally invasive surgery

Contact Info

Product

Resources

About